The document summarizes recent trends in FDA medical device regulation. It finds that after plateauing in previous years, 510(k) clearance times have recently decreased, suggesting improvements. PMA review times have also improved markedly over the past few years, with the exception of 2013 which saw an increase in panel reviews. While progress has been made, continued efforts are needed to refine review processes and ensure consistent performance across the FDA's divisions.